Status:
COMPLETED
Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Korea Health Industry Development Institute
National Research Foundation of Korea
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to refine the molecular classification of thyroid cancer (TC) using a multi-omics approach. By identifying a novel gene set and applying decision-tree modeling, the study seeks to impr...
Eligibility Criteria
Inclusion
- Patients with a confirmed clinical diagnosis of thyroid cancer
- Availability of surgically resected thyroid tissue suitable for omics analysis
Exclusion
- \- Patients who have received chemotherapy for other malignancies
Key Trial Info
Start Date :
February 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT06969768
Start Date
February 21 2018
End Date
February 28 2024
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea